195 related articles for article (PubMed ID: 25915170)
1. The causal effect of opioid substitution treatment on HAART medication refill adherence.
Nosyk B; Min JE; Colley G; Lima VD; Yip B; Milloy MJ; Wood E; Montaner JS
AIDS; 2015 May; 29(8):965-73. PubMed ID: 25915170
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs.
Nosyk B; Min JE; Evans E; Li L; Liu L; Lima VD; Wood E; Montaner JS
Clin Infect Dis; 2015 Oct; 61(7):1157-65. PubMed ID: 26113656
[TBL] [Abstract][Full Text] [Related]
3. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.
Low AJ; Mburu G; Welton NJ; May MT; Davies CF; French C; Turner KM; Looker KJ; Christensen H; McLean S; Rhodes T; Platt L; Hickman M; Guise A; Vickerman P
Clin Infect Dis; 2016 Oct; 63(8):1094-1104. PubMed ID: 27343545
[TBL] [Abstract][Full Text] [Related]
4. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B
Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275
[TBL] [Abstract][Full Text] [Related]
5. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
[TBL] [Abstract][Full Text] [Related]
6. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.
Hayashi K; Wood E; Kerr T; Dong H; Nguyen P; Puskas CM; Guillemi S; Montaner JS; Milloy MJ
BMC Infect Dis; 2016 Aug; 16(1):455. PubMed ID: 27568002
[TBL] [Abstract][Full Text] [Related]
8. Securing opioid substitution treatment access and quality for people who inject drugs.
Carrieri MP; Sagaon-Teyssier L; Roux P
AIDS; 2015 May; 29(8):975-6. PubMed ID: 25909829
[No Abstract] [Full Text] [Related]
9. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
[TBL] [Abstract][Full Text] [Related]
10. Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda.
Bagenda A; Barlow-Mosha L; Bagenda D; Sakwa R; Fowler MG; Musoke PM
Ann Trop Paediatr; 2011; 31(3):235-45. PubMed ID: 21781419
[TBL] [Abstract][Full Text] [Related]
11. Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs.
Mukandavire C; Low A; Mburu G; Trickey A; May MT; Davies CF; French CE; Looker KJ; Rhodes T; Platt L; Guise A; Hickman M; Vickerman P
AIDS; 2017 May; 31(8):1181-1190. PubMed ID: 28323752
[TBL] [Abstract][Full Text] [Related]
12. Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.
Polonsky M; Azbel L; Wickersham JA; Taxman FS; Grishaev E; Dvoryak S; Altice FL
Drug Alcohol Depend; 2015 Mar; 148():47-55. PubMed ID: 25620732
[TBL] [Abstract][Full Text] [Related]
13. "They don't like us….": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study.
Kumar S; Gupte HA; Isaakidis P; Mishra JK; Munjattu JF
PLoS One; 2018; 13(8):e0203262. PubMed ID: 30161255
[TBL] [Abstract][Full Text] [Related]
14. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada.
O'Neil CR; Palmer AK; Coulter S; O'Brien N; Shen A; Zhang W; Montaner JS; Hogg RS
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):134-41. PubMed ID: 22318879
[TBL] [Abstract][Full Text] [Related]
16. "We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine.
Mimiaga MJ; Safren SA; Dvoryak S; Reisner SL; Needle R; Woody G
AIDS Care; 2010 Nov; 22(11):1305-13. PubMed ID: 20640954
[TBL] [Abstract][Full Text] [Related]
17. People Who Inject Drugs and have tuberculosis: Opioid Substitution Therapy improves treatment outcomes in Ukraine.
Fomenko T; Meteliuk A; Korinchuk L; Denisiuk O; Aslanyan G; Islam Z; Zachariah R
J Infect Dev Ctries; 2021 Sep; 15(9.1):51S-57S. PubMed ID: 34609960
[TBL] [Abstract][Full Text] [Related]
18. Examining non-AIDS mortality among people who inject drugs.
Mathers BM; Degenhardt L
AIDS; 2014 Nov; 28 Suppl 4(4):S435-44. PubMed ID: 25409098
[TBL] [Abstract][Full Text] [Related]
19. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
[TBL] [Abstract][Full Text] [Related]
20. Coverage of highly active antiretroviral therapy among postpartum women in Malawi.
Kumwenda J; Matchere F; Mataya R; Chen S; Mipando L; Li Q; Kumwenda NI; Taha TE
Int J STD AIDS; 2011 Jul; 22(7):368-72. PubMed ID: 21729953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
